A Rare Adverse Event after CoronaVac Administration: Neutropenia in a Kidney Transplant Recipient

A Rare Adverse Event after CoronaVac Administration: Neutropenia in a Kidney Transplant Recipient

___

  • Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021;325:1784-1786. [CrossRef]
  • Heldman MR, Limaye AP. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol. 2021;32:1021-1024. [CrossRef]
  • Bird S, Panopoulou A, Shea RL, et al. Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. Lancet Haematol. 2021;8:e389-e392. [CrossRef]
  • Zafrani L, Truffaut L, Kreis H, et al. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant. 2009;9:1816-1825. [CrossRef]
  • Muturi-Kioi V, Lewis D, Launay O, et al. Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review. PLoS One. 2016;11:e0157385. [CrossRef]
  • Sing CW, Tang CTL, Chui CSL, et al. COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study. Am J Hematol. 2022;97:470-480. [CrossRef]
  • Corti C, Crimini E, Tarantino P, et al. SARS-CoV-2 vaccines for cancer patients: a call to action. Eur J Cancer. 2021;148:316-327. [CrossRef
Balkan Medical Journal-Cover
  • ISSN: 2146-3123
  • Başlangıç: 2015
  • Yayıncı: Erkan Mor